Larvol Delta - BioMimetix-Presents-Data-from-Phase-2-Study-of-BMX001-Demonstrating-Increased-Survival-of-66-Months-in-High-Grade-Glioma-Patients-at-the-2023-Society-for-NeuroOncology-Annual-Meeting

BMX-001 - BioMimetix

https://www.businesswire.com/news/home/20231117647731/en/BioMimetix-Presents-Data-from-Phase-2-Study-of-BMX-001-Demonstrating-Increased-Survival-of-6.6-Months-in-High-Grade-Glioma-Patients-at-the-2023-Society-for-Neuro-Oncology-Annual-Meeting

Nov 17, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next